| 貨號 | 規(guī)格 | 價格 | 上海 | 北京 | 武漢 | 南京 | 購買數(shù)量 |
|---|---|---|---|---|---|---|---|
S80487-2mg |
99.9% | ￥340.00 | 5 | - | - | - |
|
S80487-5mg |
99.9% | ￥450.00 | 6 | - | - | - |
|
S80487-10mg |
99.9% | ￥637.50 | 5 | - | - | - |
|
S80487-25mg |
99.9% | ￥1090.00 | 7 | - | - | - |
|
S80487-50mg |
99.9% | ￥1620.00 | 6 | - | - | - |
|
S80487-100mg |
99.9% | ￥2400.00 | 5 | - | - | - |
|
S80487-200mg |
≥98% | ￥3500.00 | 貨期：2-3天 | - | - | - |
|
Tipiracil (hydrochloride) is a thymidine phosphorylase inhibitor (TPI), used for cancer research
| 產(chǎn)品描述： | Tipiracil (hydrochloride) is a thymidine phosphorylase inhibitor (TPI), used for cancer research | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點： | Nucleoside Antimetabolite/Analog;NucleosideAntimetabolite/Analog | ||||||||||||||||||||
| 體外研究： | Tipiracil has antiangiogenic effect, and inhibits proliferation of endothelial cells. Tipiracil is a potent inhibitor of thymidine phosphorylase, which is the enzyme that degrades FTD | ||||||||||||||||||||
| 參考文獻： | 1. Peters GJ, et al. TAS-102: more than an antimetabolite. Lancet Oncol. 2012 Dec;13(12):e518-9. 2. Yoshino T, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 2012 Oct;13(10):993-1001. | ||||||||||||||||||||
| 溶解性： | Soluble in H2O | ||||||||||||||||||||
| 保存條件： | -20℃ | ||||||||||||||||||||
| 配置溶液濃度參考： |
|
||||||||||||||||||||
| 注意： | 部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
滬公網(wǎng)安備 31011702002021號
危險品化學(xué)品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京